| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $489.95K | $490.44K | $471.95K | $485.51K | $501.95K |
| R&D | – | – | – | – | – |
| SG&A | $66.95K | $67.44K | $48.95K | $62.51K | $78.95K |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$1.29M | -$490.44K | -$471.95K | -$485.51K | -$501.95K |
| EPS (basic) | -0.0400 | -0.0200 | -0.0200 | -0.0200 | – |
| EPS (diluted) | -0.0400 | -0.0200 | -0.0200 | -0.0200 | – |
| Shares (diluted) | $33.21M | $29.27M | $29.27M | $29.27M | – |